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Heart transplantation remains the gold standard treatment for end-stage heart 
failure. To face actual donor shortage, heart warm perfusion with the Organ Care 
System (OCS) was introduced alternatively to usual cold ischemic storage [1]. Here, 
OCS-preserved hearts were matched against those subjected to cold ischemia in terms 
of (i) perioperative clinical parameters, (ii) histopathological, immunohistochemical, 
and ultrastructural features of pre- and post-implant left ventricle biopsies, and (iii) 
cardiomyocyte metabolism by NMR spectroscopy of blood samples. Concerning clini-
cal outcomes and myocardium structural preservation, preliminary data seem to be 
encouraging. Namely, NMR spectra revealed OCS perfusion to reduce cardiomyocyte 
oxidative stress by lowering the lactate/glucose ratio. Ultrastructurally, cardiomyo-
cytes from OCS-preserved hearts showed minor hypertrophy signs and few altered 
mitochondria. OCS preservation also seemed to mitigate reperfusion effects, decreas-
ing the number of degenerating cardiomyocytes. Interestingly, disappearance of sar-
comere banding in one heart undergone pre-explant arrest was found to be restored 
after OCS perfusion. In conclusion, these preliminary data suggest that the OCS can 
improve heart storage. Functional recovery of borderline hearts with actual broaden-
ing of the donor pool seems to represent additional advantages of OCS technology.
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